DK306587D0 - Farmaceutisk kapsel med langvarig frigoerelse til oral indgivelse og fremgangsmaade til fremstilling af samme - Google Patents

Farmaceutisk kapsel med langvarig frigoerelse til oral indgivelse og fremgangsmaade til fremstilling af samme

Info

Publication number
DK306587D0
DK306587D0 DK306587A DK306587A DK306587D0 DK 306587 D0 DK306587 D0 DK 306587D0 DK 306587 A DK306587 A DK 306587A DK 306587 A DK306587 A DK 306587A DK 306587 D0 DK306587 D0 DK 306587D0
Authority
DK
Denmark
Prior art keywords
procedure
long
oral administration
producing same
term release
Prior art date
Application number
DK306587A
Other languages
English (en)
Other versions
DK306587A (da
Inventor
Vikram Suresh Patel
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of DK306587D0 publication Critical patent/DK306587D0/da
Publication of DK306587A publication Critical patent/DK306587A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
DK306587A 1986-06-16 1987-06-16 Farmaceutisk kapsel med langvarig frigoerelse til oral indgivelse og fremgangsmaade til fremstilling af samme DK306587A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/874,732 US4798725A (en) 1986-06-16 1986-06-16 Sustained release capsule

Publications (2)

Publication Number Publication Date
DK306587D0 true DK306587D0 (da) 1987-06-16
DK306587A DK306587A (da) 1987-12-17

Family

ID=25364440

Family Applications (1)

Application Number Title Priority Date Filing Date
DK306587A DK306587A (da) 1986-06-16 1987-06-16 Farmaceutisk kapsel med langvarig frigoerelse til oral indgivelse og fremgangsmaade til fremstilling af samme

Country Status (13)

Country Link
US (1) US4798725A (da)
EP (1) EP0250038B1 (da)
JP (1) JPH0830007B2 (da)
AT (1) AT398165B (da)
AU (1) AU589866B2 (da)
CA (1) CA1295247C (da)
DE (1) DE3772269D1 (da)
DK (1) DK306587A (da)
IE (1) IE60586B1 (da)
IL (1) IL82806A (da)
NZ (1) NZ220696A (da)
PH (1) PH25179A (da)
ZA (1) ZA874315B (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form
HU202753B (en) * 1986-06-21 1991-04-29 Sandoz Ag Process for producing retard pharmaceutical compositions containing cetotiphene
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5178880A (en) * 1989-07-25 1993-01-12 Norwich Eaton Pharmaceuticals, Inc. Liquid suspensions of nitrofurantoin
US5332832A (en) * 1989-07-26 1994-07-26 Procter & Gamble Pharmaceuticals, Inc. Nitrofurantoin crystals
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5484607A (en) * 1993-10-13 1996-01-16 Horacek; H. Joseph Extended release clonidine formulation
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
AU717113B2 (en) 1995-11-09 2000-03-16 Health Protection Agency Microencapsulated DNA for vaccination and gene therapy
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
IN186245B (da) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
WO2000038731A1 (en) * 1998-12-28 2000-07-06 Taisho Pharmaceutical Co.,Ltd. External preparation
US6383515B2 (en) 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US6372252B1 (en) 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
ES2196948B1 (es) * 2001-03-29 2005-02-01 Easyblind, S.L. Persiana enrollable perfeccionada.
US20030012820A1 (en) * 2001-06-12 2003-01-16 Upadhyay Ajay Hasmukhlal Compressible guaifenesin compositions, method for making same and method for making compressed guaifenesin dosage forms therefrom
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
CA2479350A1 (en) * 2002-03-15 2003-09-25 Cypress Bioscience, Inc. Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
BR0317412A (pt) * 2002-12-16 2005-11-08 Ranbaxy Lab Ltd Composição farmacêutica de liberação prolongada de fenitoìna de sódio e processo para sua preparação
JP2006515008A (ja) * 2003-01-28 2006-05-18 コレギウム ファーマシューティカル， インコーポレイテッド 経口投与のためのミルナシプランの多粒子状組成物
US20050152967A1 (en) * 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
JPWO2007023729A1 (ja) * 2005-08-23 2009-02-26 日産化学工業株式会社 徐放性製剤
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
JP4926495B2 (ja) * 2006-02-22 2012-05-09 興和株式会社 イブプロフェン含有コーティング顆粒
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
US20100172991A1 (en) * 2007-06-08 2010-07-08 Henry Joseph Horacek Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
MX2009013384A (es) * 2007-06-08 2010-01-25 Addrenex Pharmaceuticals Inc Formulacion de liberacion extendida, y metodo para tratar disregulacion adrenergica.
CA3001337C (en) 2015-10-09 2023-12-12 Reckitt Benckiser Llc Pharmaceutical formulation
EP4285895A1 (en) 2022-06-03 2023-12-06 Adalvo Limited Nitrofurantoin oral dosage form

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE515245A (da) * 1950-05-29
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
US3427378A (en) * 1965-02-12 1969-02-11 American Cyanamid Co Sustained release encapsulated formula
GB1093286A (en) * 1965-02-15 1967-11-29 Biorex Laboratories Ltd Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
GB1204580A (en) * 1968-10-05 1970-09-09 Aspro Nicholas Ltd Pharmaceutical dosage forms
US3634584A (en) * 1969-02-13 1972-01-11 American Home Prod Sustained action dosage form
US3851051A (en) * 1970-07-17 1974-11-26 Scherer R Corp Soft gelatin capsule containing high water content fill
US4152444A (en) * 1972-04-19 1979-05-01 Ciba-Geigy Corporation Pharmaceutical compound preparations with bactericidal action
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
FR2287216A1 (fr) * 1974-10-09 1976-05-07 Narcisse Guy Nouvelle forme galenique d'administration de medicaments et medicaments prepares sous cette nouvelle forme
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
FR2407720A1 (fr) * 1977-11-08 1979-06-01 Lipha Lyonnaise Indle Pharmace Preparations pharmaceutiques orales a activite therapeutique prolongee
US4247552A (en) * 1979-01-11 1981-01-27 Syntex (U.S.A.) Inc. Contraceptive compositions and methods employing 1-substituted imidazole derivatives
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system

Also Published As

Publication number Publication date
NZ220696A (en) 1990-08-28
JPS63258407A (ja) 1988-10-25
EP0250038A2 (en) 1987-12-23
DE3772269D1 (de) 1991-09-26
EP0250038A3 (en) 1989-01-18
IL82806A (en) 1990-11-29
US4798725A (en) 1989-01-17
IE60586B1 (en) 1994-07-27
IL82806A0 (en) 1987-12-20
AU7421287A (en) 1987-12-17
AT398165B (de) 1994-10-25
AU589866B2 (en) 1989-10-19
ATA151587A (de) 1994-02-15
JPH0830007B2 (ja) 1996-03-27
ZA874315B (en) 1988-08-31
DK306587A (da) 1987-12-17
PH25179A (en) 1991-03-27
IE871584L (en) 1987-12-16
EP0250038B1 (en) 1991-08-21
CA1295247C (en) 1992-02-04

Similar Documents

Publication Publication Date Title
DK306587A (da) Farmaceutisk kapsel med langvarig frigoerelse til oral indgivelse og fremgangsmaade til fremstilling af samme
DK306487D0 (da) Farmaceutisk kapsel med langvarig/hurtig frigoerelse til oral indgivelse af nitrofurantoin og fremgangsmaade til fremstilling af samme
DK495585A (da) Farmaceutisk praeparat med kontrolleret frigivelse og fremgangsmaade til fremstilling af samme
DK52787D0 (da) Laegemiddelpraeparat med protraheret virkning og fremgangsmaade til fremstilling heraf
NO871243L (no) Farmasoeytisk preparat med langvarig frigjoering og fremgangsmaate for dets fremstilling.
DK215887A (da) Farmaceutisk praeparat af omeprazol til oral ind- gift
DK16487D0 (da) Vacciner til oral indgift
DK287687D0 (da) Nyt laegemiddelpraeparat med kontrolleret frigivelse af den virksomme forbindelse, fremgangsmaade til fremstilling deraf og anvendelse af det nye praeparat
DK165830C (da) Selvbaerende keramisk komposit og fremgangsmaade til fremstilling deraf
DK664387A (da) Fremgangsmaade til fremstilling af et anti-inflammatorisk farmaceutisk praeparat
DK708088A (da) Farmaceutisk praeparat med forlaenget frigivelsestid
DK52887D0 (da) Laegemiddelpraeparat med protraheret frigoerelse og fremgangsmaade til fremstilling heraf
DK153387A (da) Fremgangsmaade til fremstilling af laegemiddel-adsorbater
DK529885D0 (da) Farmaceutiske kapsler med langvarig frigivelse
DK106989D0 (da) Isoindolinonderivat, fremgangsmaade til fremstilling af dette, og laegemiddel indeholdende dette
DK16187A (da) Farmaceutisk sammensaetning med langvarig frigoerelse og fremgangsmaade til fremstilling af samme
DK633987A (da) Lactamderivater og fremgangsmaade til deres fremstilling
DK420687D0 (da) Injicerbart farmaceutisk praeparat til inducering og opretholdelse af anaestesi, samt en fremgangsmaade til anvendelse heraf
DK424987D0 (da) Farmaceutisk praeparat til indgivelse gennem huden og fremgangsmaade til dets fremstilling
DK152087D0 (da) Indretning og fremgangsmaade til indstilling af tandlaegestol
DK701588A (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
DK173287A (da) Perhydrothiazepin- og perhydroazepinderivater og fremgangsmaade til fremstilling deraf
DK670588D0 (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK617187A (da) Fremgangsmaade til fremstilling af tabeletter med clovoxamin-fumarat og de saaledes fremstillede tabletter
DK711988D0 (da) Methyltetrahydropyridyloxadiazol, farmaceutisk praeparat indeholdende en saadan forbindelse og fremgangsmaade til fremstilling af en saadan forbindelse

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment